menu search

Inovio shares rise after positive fda feedback on rrp treatment candidate

Biotechnology company Inovio saw its shares jump after the US FDA communicated that data from Inovio completed Phase 1/2 trial of INO-3107 for treatin...

October 10, 2023, 2:47 pm

Top investor at warren buffet's berkshire hathaway says he landed gig by not ‘kissing ass'

Todd Combs recalled landing his top job at Warren Buffet's Berkshire Hathaway on an episode of the "Art of Investing" podcast. Combs recalled being ve...

October 10, 2023, 2:03 pm

Down 45%, is intellia a buy?

Intellia has declined over the past year even as its candidates for severe diseases have advanced in cl...

October 10, 2023, 2:00 pm

Novavax (nvax) focuses on diversifying vaccines portfolio

Owing to the slow uptake of Novavax's (NVAX) COVID-19 vaccine, the company is trying to develop other vaccine ...

October 10, 2023, 1:33 pm

Why shares of ventyx biosciences are dropping tuesday

Ventyx is a clinical-stage biotech that focuses on autoimmune disorders. The company's lead therapy candid...

October 10, 2023, 12:55 pm

Tango therapeutics (tngx) rises 20% in a month: here's why

The upside in Tango's (TNGX) shares can be attributed to the company's progress with its pipeline candid...

October 10, 2023, 12:47 pm

Beam focuses on developing gene drug for growth

While BEAM's pipeline candidates are in early-stage clinical studies, their development is progressing ...

October 10, 2023, 11:16 am

Lyra therapeutics: hold for phase 3 topline

Lyra Therapeutics has two product candidates in clinical trials for Chronic rhinosinusitis (CRS) patien...

October 10, 2023, 10:56 am

Ocugen mucosal vaccine candidate ocu500 selected by nih/niaid project nextgen for inclusion in clinical trials

NIAID is conducting early phase clinical trials on select next generation vaccine candidates with the i...

October 10, 2023, 10:30 am

This cathie wood stock is poised to double, says wall street

Intellia's leading candidates look promising, but there's a long way to go before they hit the market. ...

October 10, 2023, 10:07 am

Filament health says health canada authorizes phase 2 clinical trial studying botanical psilocybin for opioid use disorder

Filament Health Corp (OTCQB:FLHLF, NEO:FH) told investors that Health Canada has approved a phase 2 clinical trial of its botanical psilocybin drug ...

October 10, 2023, 8:21 am

Akero therapeutics shares plunge on liver disease treatment's mixed results

Akero Therapeutics Inc. shares AKRO, -3.56% fell more than 60% premarket on Tuesday after the company released an update on its lead product ...

October 10, 2023, 8:10 am

A bull market is coming: 1 beaten-down growth stock you could regret not buying on the dip

Caribou Biosciences stock could rocket up more than 400%, according to the consensus price target from Wall Street analysts. Caribou's lead ...

October 10, 2023, 5:40 am

Fortress biotech announces reverse stock split

MIAMI, Oct. 09, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or the “Company”), an innovative biopharmaceutical...

October 9, 2023, 4:50 pm

Sutro biopharma: luvelta data for endometrial cancer treatment approaching

Sutro Biopharma is advancing its lead candidate, luvelta, for the treatment of various types of cancer,...

October 9, 2023, 9:48 am

Terns pharmaceuticals: business model does not impress

Terns Pharmaceuticals stock is down 15% in the past 10 months, despite bullish articles following a bearish prediction. The company initially planned ...

October 9, 2023, 9:19 am

Boot barn: a solid buy-the-dip candidate

Boot Barn has seen impressive share price performance over the past year, massively outperforming its peers in the retail sector. And while the compan...

October 7, 2023, 10:11 pm

Neurosense: a hold ahead of phase 2b als data

NeuroSense Therapeutics will report Phase 2b trial data for its ALS drug candidate, PrimeC, in Q4 2023....

October 6, 2023, 6:51 pm

Structure therapeutics (gpcr) stock up 9% this week: here's why

Structure Therapeutics (GPCR) rises 9% on encouraging initial data from the early-stage study of its pipeline ...

October 6, 2023, 9:46 am

Did moderna just jump ahead of rivals in a potential billion-dollar market?

Moderna just reported positive data from its combined flu/coronavirus vaccine candidate and aims to lau...

October 6, 2023, 6:00 am


Search within

Pages Search Results: